Cytokinetics Inc (NASDAQ:CYTK)

7.73
Delayed Data
As of 9:52am ET
 +0.075 / +0.98%
Today’s Change
7.00
Today|||52-Week Range
17.20
-5.21%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close7.65
Today’s open7.75
Day’s range7.60 - 7.85
Volume30,816
Average volume (3 months)671,684
Market cap$412.2M
Data as of 9:52am ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-764.10%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-87.44%
P/E ratioNM
Price/Sales30.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.30+1.72%
FLXNFlexion Therapeutics...+0.55+2.24%
ACRSAclaris Therapeutics...+0.11+0.55%
AKBAAkebia Therapeutics ...+0.30+2.10%
Data as of 10:08am ET, 02/22/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$13.4M
Annual profit (last year)-$127.8M
Net profit margin-955.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts